This Senior Medical Director will partner with the Head, US Medical Affairs to deliver the US medical affairs strategy for Oncology. The focus will be on lung cancer but also an ever-increasing role in newer therapies (Immuno-oncology, pipeline compounds) that will enter the solid tumor and hematologic malignancy space.
The Senior Medical Director will provide leadership to a multifunctional, matrixed US medical affairs team, including medical communications, medical publications, medical information, medical education, strategic alliances, and other medical affairs professionals.
This role will be responsible for ensuring compliance with and maintenance of excellence in standards and practices. This includes advancing collaborations with key opinion leaders in lung cancer, community hospital systems, large oncology practice groups , community oncologists, and health care practitioners. The role will also involve collaboration with research groups, payers, and patient advocacy groups. This position will also provide medical and scientific leadership for both Takeda sponsored clinical trial study sites, but also for the oversight of individual investigator sponsored studies in lung/solid tumors including GMA clinical studies.
- Develop an in-depth understanding of the needs of oncology patients and demonstrate a focus on activities to meet those needs
- US strategy development for solid tumor malignancies including pipeline molecules and acquisitions
- Participate in US Leadership Team to define and implement strategy for both solid tumor and hematologic malignancy applications
- Participate as a member of the Brigatinib brand team
- Participate in the development of the US/global medical affairs plan
- Work closely with Takeda medical science liaisons (MSLs) with regard to scientific education, advisory boards, community clinical trial sites, interactions with community health care professionals and small/medium payer accounts
- Work with Global Oncology Business Unit (GOBU) leads to support US medical affairs activities
- Provide scientific expertise in the development of non-promotional and promotional materials
- Work closely with alliance partners and with clinical development and commercial
- Provide strategic assessments of opportunities and threats regarding the treatment of MM patients in the US.
- Lead a broad range of medical affairs activities, including serving as medical monitor for US Takeda-sponsored medical affairs studies, internal training, and conducting advisory boards
- Foster research relationships with academic key opinion leaders, community hospital centers and key US community oncologists
- Interact regularly with key medical opinion leaders
- Provide medical leadership for investigator initiated studies (IIS) program
- Responsible for medical affairs clinical trials in solid tumor malignancies
- Interact with NCI/CTEP regarding investigational studies with Takeda solid tumor molecules on CRADA
- Assist global medical affairs for launch activities of lung cancer therapeutics as appropriate
- Responsible for US thought leader development
EDUCATION, BEHAVIORAL COMPETENCIES AND SKILLS:
- Medical Degree
- Demonstrated focus on patients interest
- Ideal candidate will have worked in lung/solid tumor space
- Minimum of 10 years combined post-clinical MD/industry experience
- Must have conducted or participated in clinical trials with track record of patient accrual
- Must have experience in medical oncology.
- In-depth understanding of the lung cancer research environment
- Knowledge of the immuno-oncology field in lung/solid tumors is a key plus.
- Requires experience and success in working in a matrixed, cross-functional environment; excellent collaboration skills; experience working across functions to achieve results.
Empowering Our People to Shine
Learn more at takedajobs.com.
No Phone Calls or Recruiters Please.